No photo of David D Stenehjem
Contact Expert

View Scopus Profile

David D Stenehjem

 https://orcid.org/0000-0002-1831-285X
20092020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Steady-state pharmacokinetics of osimertinib stratified by CYP1A2 and CYP2D6 genotypes

Brown, J. T. & Stenehjem, D. D.

Whiteside Inst. for Clinical Research

1/1/20 → 12/31/20

Project: Research project

    • Cost effectivness of multiplexed predictive tumor mutational burden in lung cancer using real world data

    Stenehjem, D. D.

    University of Utah

    1/1/19 → 12/31/19

    Project: Research project

    • Feasibility study to identify non-small cell lung cancer patients with EGFR mutation within the Oncology Research Information Exchange Network (ORIEN)

    Stenehjem, D. D.

    University of Utah

    8/1/18 → 1/31/19

    Project: Research project

    • BMS CA209-8D9 Analytics

    Stenehjem, D. D.

    University of Utah

    8/1/18 → 7/31/19

    Project: Research project

    Novel drugs targeting metabolic plasticity for breast ca

    Mereddy, V. R., Potter, D. A. & Stenehjem, D. D.

    Whiteside Inst. for Clinical Research

    2/1/18 → 12/31/19

    Project: Research project

    • Research Output

    Comparative efficacy and safety of interventions for preventing chemotherapy-induced oral mucositis in adult cancer patients: A systematic review and network meta-analysis

    Wilairat, P., Kengkla, K., Kaewpanan, T., Kaewthong, J., Ruankon, S., Subthaweesin, C., Stenehjem, D. D. & Saokaew, S., Mar 1 2020, In : European Journal of Hospital Pharmacy. 27, 2, p. 103-110 8 p.

    Research output: Contribution to journal › Article

    • 1 Scopus citations

    Clinical and economic analysis of patients with acute myeloid leukemia by FLT3 status and midostaurin use at a Comprehensive Cancer Center

    Willis, C., Menon, J., Unni, S., Au, T., Yoo, M., Biskupiak, J., Brixner, D., Ndife, B., Joseph, G., Bonifacio, G., Stein, E., Tantravahi, S., Shami, P. J., Kovacsovics, T. & Stenehjem, D., Dec 2019, In : Leukemia research. 87, 106262.

    Research output: Contribution to journal › Article

    • Dynamic dosing of romiplostim in patients with immune thrombocytopenia purpura: Two case reports

    Gilreath, J. A., Wei, M., Paul, S., Parker, C. J., Stenehjem, D. D. & Rodgers, G. M., Apr 1 2019, In : Journal of Oncology Pharmacy Practice. 25, 3, p. 719-723 5 p.

    Research output: Contribution to journal › Article

    • Evolution of the genomic landscape of circulating tumor DNA (ctDNA) in metastatic prostate cancer over treatment and time

    Hahn, A. W., Stenehjem, D. D., Nussenzveig, R., Carroll, E., Bailey, E., Batten, J., Maughan, B. L. & Agarwal, N., Jan 1 2019, In : Cancer Treatment and Research Communications. 19, 100120.

    Research output: Contribution to journal › Article

    • 2 Scopus citations

    Immunotargeted therapy in melanoma: patient, provider preferences, and willingness to pay at an academic cancer center

    Stenehjem, D. D., Au, T. H., Ngorsuraches, S., Ma, J., Bauer, H., Wanishayakorn, T., Nelson, R. S., Pfeiffer, C. M., Schwartz, J., Korytowsky, B., Oderda, G. & Brixner, D. I., Dec 1 2019, In : Melanoma research. 29, 6, p. 626-634 9 p.

    Research output: Contribution to journal › Article

    Open Access
    • 1 Scopus citations